Advertisement

Canada Approves Pfizer COVID-19 Vaccine

0

Health Canada completed a full independent review of the data on the vaccine's safety and effectiveness

HealthDay Reports: Sanofi Speeds COVID-19 Vaccine Efforts

COVID-19 Vaccine Caution Issued by U.K. Officials

0

Warning issued after two people suffered adverse reactions on the first day of the U.K. mass vaccination program

La vacuna de Pfizer contra la COVID parece promisoria

ASH: Adding Subcutaneous Daratumumab Slows Advanced Multiple Myeloma

0

Subcutaneous daratumumab plus pomalidomide and dexamethasone reduces risk of progression, death in relapsed/refractory MM

Vitamin D Supplementation Tied to Reduction in Advanced Cancer

Vitamin D3 Supplementation No Benefit for Fall Prevention

0

Doses of 1,000 IU/day or higher did not prevent falls compared with 200 IU/day in those with elevated risk, low serum 25(OH)D

Pfizer COVID-19  Vaccine Reaches 90 Percent Effectiveness in Early Analysis

FDA Review Finds Pfizer COVID-19 Vaccine Effective After First Dose

0

Vaccine is expected to receive emergency use authorization later this week

Las muertes por opioides entre los estadounidenses jóvenes con frecuencia implican a otras sustancias

Youth Opioid Deaths Often Involve Other Substances, Too

0

In 2018, more than half of opioid overdose deaths involved polysubstance, most commonly cocaine

Global Need High for Rehabilitation Services

0

Musculoskeletal disorders contributed most to prevalence; highest need for rehabilitation services seen in Western Pacific region

Uno de cada tres estadounidenses recibe recetas de medicamentos inadecuados

Glucocorticoid Use Tied to CVD Risk in Immune-Mediated Diseases

0

Risk for CVD increased in association with glucocorticoid dose, even with <5.0 mg daily prednisolone-equivalent dose

AstraZeneca  J&J Resume U.S. COVID-19 Vaccine Trials

Flu Shot More Popular Than COVID-19 Vaccine Among Older Adults

0

58 percent of adults aged 50 to 80 years report being somewhat or very likely to get a COVID-19 vaccine

Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness

Antiviral Drugs Have No Effect on Mortality in COVID-19

0

Remdesivir, hydroxychloroquine, lopinavir, interferon regimens have little to no effect on in-hospital mortality